Reviewed,
UniProtKB/Swiss-Prot Q9NQR9 (G6PC2_HUMAN)
Last modified
July 7, 2009.
Version 51.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Glucose-6-phosphatase 2 Short name=G-6-Pase 2 Short name=G6Pase 2 EC=3.1.3.9 Alternative name(s): Islet-specific glucose-6-phosphatase catalytic subunit-related protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 355 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May hydrolyze glucose-6-phosphate to glucose in the endoplasmic reticulum. May be responsible for glucose production through glycogenolysis and gluconeogenesis By similarity. |
| Catalytic activity | D-glucose 6-phosphate + H2O = D-glucose + phosphate. Ref.6 |
| Pathway | |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein. Ref.5 |
| Tissue specificity | Specifically expressed in pancreas and also detected to a lower extent in testis. Expressed by most islet cells in the pancreas (at protein level). Ref.1 |
| Post-translational modification | N-glycosylated; the non-glycosylated form is more unstable and is degraded through the proteasome. Ref.5 |
| Involvement in disease | Genetic variation in G6PC2 is associated with fasting plasma glucose levels quantitative trait locus type 1 (FGQTL1) [MIM:612108]. The normal fasting plasma glucose level in the plasma is defined as less than 100 mg per deciliter (5.55 mmol per liter). Higher fasting plasma glucose levels predict type 2 diabetes in young adults and increases the risk of mortality. Ref.8 |
| Sequence similarities | Belongs to the glucose-6-phosphatase family. |
| Biophysicochemical properties | Kinetic parameters: KM=0.45 mM for glucose-6-phosphate (at pH 6.5) |
Ontologies
| Keywords | |
|---|---|
| Biological process | Gluconeogenesis |
| Cellular component | Endoplasmic reticulum Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Transmembrane |
| Molecular function | Hydrolase |
| PTM | Glycoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | gluconeogenesis Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | endoplasmic reticulum membrane Inferred from electronic annotation. Source: UniProtKB-SubCell integral to membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | glucose-6-phosphatase activity Inferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NQR9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NQR9-2) The sequence of this isoform differs from the canonical sequence as follows: 74-102: ILFGHRPYWWVQETQIYPNHSSPCLEQFP → KSIWPCNGRILCLVCHGNRCPEPHCLWDG 103-355: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 355 | 355 | Glucose-6-phosphatase 2 | PRO_0000334509 | |||||
Regions | |||||||||
| Topological domain | 1 – 24 | 24 | Lumenal Potential | ||||||
| Transmembrane | 25 – 45 | 21 | Potential | ||||||
| Topological domain | 46 – 56 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 57 – 77 | 21 | Potential | ||||||
| Topological domain | 78 – 115 | 38 | Lumenal Potential | ||||||
| Transmembrane | 116 – 136 | 21 | Potential | ||||||
| Topological domain | 137 – 146 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 147 – 167 | 21 | Potential | ||||||
| Topological domain | 168 | 1 | Lumenal Potential | ||||||
| Transmembrane | 169 – 189 | 21 | Potential | ||||||
| Topological domain | 190 – 211 | 22 | Cytoplasmic Potential | ||||||
| Transmembrane | 212 – 232 | 21 | Potential | ||||||
| Topological domain | 233 – 261 | 29 | Lumenal Potential | ||||||
| Transmembrane | 262 – 282 | 21 | Potential | ||||||
| Topological domain | 283 – 293 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 294 – 314 | 21 | Potential | ||||||
| Topological domain | 315 – 318 | 4 | Lumenal Potential | ||||||
| Transmembrane | 319 – 339 | 21 | Potential | ||||||
| Topological domain | 340 – 355 | 16 | Cytoplasmic Potential | ||||||
| Motif | 352 – 355 | 4 | Prevents secretion from ER Potential | ||||||
Sites | |||||||||
| Active site | 115 | 1 | Proton donor Potential | ||||||
| Active site | 174 | 1 | Nucleophile By similarity | ||||||
| Binding site | 79 | 1 | Substrate Potential | ||||||
| Binding site | 168 | 1 | Substrate Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 92 | 1 | N-linked (GlcNAc...) Ref.5 | ||||||
Natural variations | |||||||||
| Alternative sequence | 74 – 102 | 29 | ILFGH…LEQFP → KSIWPCNGRILCLVCHGNRC PEPHCLWDG in isoform 2. | VSP_033648 | |||||
| Alternative sequence | 103 – 355 | 253 | Missing in isoform 2. | VSP_033649 | |||||
| Natural variant | 171 | 1 | I → V: dbSNP rs2232322. | VAR_043372 | |||||
| Natural variant | 207 | 1 | Y → S: dbSNP rs2232323. | VAR_043373 | |||||
| Natural variant | 219 | 1 | V → L: dbSNP rs492594. | VAR_043374 | |||||
| Natural variant | 324 | 1 | S → P: dbSNP rs2232326. | VAR_043375 | |||||
| Natural variant | 340 | 1 | P → L: dbSNP rs2232327. | VAR_043376 | |||||
| Natural variant | 342 | 1 | S → C: dbSNP rs2232328. | VAR_043377 | |||||
Experimental info | |||||||||
| Mutagenesis | 50 | 1 | N → A: No effect on N-glycosylation. Ref.5 | ||||||
| Mutagenesis | 92 | 1 | N → A: Loss of N-glycosylation. Ref.5 | ||||||
| Mutagenesis | 287 | 1 | N → A: No effect on N-glycosylation. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes." Martin C.C., Bischof L.J., Bergman B., Hornbuckle L.A., Hilliker C., Frigeri C., Wahl D., Svitek C.A., Wong R., Goldman J.K., Oeser J.K., Lepretre F., Froguel P., O'Brien R.M., Hutton J.C. J. Biol. Chem. 276:25197-25207(2001) [PubMed: 11297555] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHARACTERIZATION, TISSUE SPECIFICITY. |
| [2] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., Heubner D., Hoerlein A., Michel G., Wedler H., Kohrer K., Ottenwalder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Retina. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Cerebellum. |
| [5] | "The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane." Shieh J.-J., Pan C.-J., Mansfield B.C., Chou J.Y. FEBS Lett. 562:160-164(2004) [PubMed: 15044018] [Abstract] Cited for: SUBCELLULAR LOCATION, TOPOLOGY, MUTAGENESIS OF ASN-50; ASN-92 AND ASN-287, GLYCOSYLATION AT ASN-92. |
| [6] | "Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP)." Petrolonis A.J., Yang Q., Tummino P.J., Fish S.M., Prack A.E., Jain S., Parsons T.F., Li P., Dales N.A., Ge L., Langston S.P., Schuller A.G.P., An W.F., Tartaglia L.A., Chen H., Hong S.-B. J. Biol. Chem. 279:13976-13983(2004) [PubMed: 14722102] [Abstract] Cited for: CATALYTIC ACTIVITY. |
| [7] | "Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas." Dogra R.S., Vaidyanathan P., Prabakar K.R., Marshall K.E., Hutton J.C., Pugliese A. Diabetologia 49:953-957(2006) [PubMed: 16520917] [Abstract] Cited for: ALTERNATIVE SPLICING. |
| [8] | "A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels." Bouatia-Naji N., Rocheleau G., Van Lommel L., Lemaire K., Schuit F., Cavalcanti-Proenca C., Marchand M., Hartikainen A.-L., Sovio U., De Graeve F., Rung J., Vaxillaire M., Tichet J., Marre M., Balkau B., Weill J., Elliott P., Jarvelin M.-R. Froguel P.Science 320:1085-1088(2008) [PubMed: 18451265] [Abstract] Cited for: INVOLVEMENT IN FGQTL1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AF283835 Genomic DNA. Translation: AAF82810.1. CR627438 mRNA. Translation: CAH10524.1. CH471058 Genomic DNA. Translation: EAX11291.1. BC104778 mRNA. Translation: AAI04779.1. BC113376 mRNA. Translation: AAI13377.1. | |
| IPI | IPI00028155. IPI00465025. |
| RefSeq | NP_001075155.1. NP_066999.1. |
| UniGene | Hs.283963 |
3D structure databases | |
| ModBase | Search... |
Proteomic databases | |
| PRIDE | Q9NQR9. |
Genome annotation databases | |
| Ensembl | ENSG00000152254. Homo sapiens. [Contig view] |
| GeneID | 57818. |
| KEGG | hsa:57818. |
| UCSC | uc002uem.1. human. |
Organism-specific databases | |
| GeneCards | GC02P169466. |
| HGNC | HGNC:28906. G6PC2. |
| MIM | 608058. gene. 612108. phenotype. |
| PharmGKB | PA134944773. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | Q9NQR9. |
| HOVERGEN | Q9NQR9. |
| OMA | Q9NQR9. HQVILGV. |
Gene expression databases | |
| ArrayExpress | Q9NQR9. |
| Bgee | Q9NQR9. |
| CleanEx | HS_G6PC2. |
Family and domain databases | |
| InterPro | IPR016275. Glucose-6-phosphatase. IPR000326. P_Acid_Pase_2/haloperoxidase. [Graphical view] |
| Pfam | PF01569. PAP2. 1 hit. [Graphical view] |
| PIRSF | PIRSF000905. Glucose-6-phosphatase. 1 hit. |
| SMART | SM00014. acidPPc. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 64766. |
| SOURCE | Search... |
Entry information
| Entry name | G6PC2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NQR9 Secondary accession number(s): Q6AHZ0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with


